Following immunization with collagen II (CII) in complete Freund's adjuvant (CFA), DBA/1 mice develop arthritis of major joints. This collagen-induced arthritis (CIA) is used as a model for rheumatoid arthritis (RA) in man. Inflammatory changes in lung tissue commonly occur in RA. However, evidence for pulmonary inflammation in CIA is scarce and ambiguous. Here, we demonstrate pulmonary inflammation accompanying CIA in wild-type DBA/1 mice. In IFN-γ receptor-deficient (IFN-γR KO) mice, inflammation was more frequent and more severe. Injection of CFA only (without CII) proved to be as efficient in eliciting pulmonary inflammation as immunization with CFA + CII, though being less effective in causing arthritis. Significant correlation in severity between joint and pulmonary involvement could not be demonstrated. Macroscopic, microscopic, and functional characteristics of pulmonary inflammation in the mice resembled those seen in human RA. Increased inflammation in IFN-γR KO mice was accompanied by augmented expression of various cytokines and chemokines, as measured by RT-PCR on affected tissue. Treatment with a TNF-α inhibitor ameliorated lung pathology. We conclude that CIA in DBA/1 mice is accompanied by pulmonary inflammation. Although both disease processes are kept in check by endogenous IFN-γ, lack of strict parallelism indicates that overlap in their pathogeneses is partial.
Keywords: Arthritis r IFN-γ r Lung
IntroductionFollowing immunization with collagen II (CII) in complete Freund's adjuvant (CFA), DBA/1 mice develop arthritis of major joints [1]. This experimental system, called collagen-induced arthritis (CIA), is used as a study model for rheumatoid arthritis Correspondence: Prof. Patrick Matthys e-mail: patrick.matthys@rega.kuleuven.be (RA) in man [2][3][4]. RA is usually categorized as an autoimmune disease. However, in contrast to what is the case for typical autoimmune diseases, for example type I diabetes, a break in tolerance for any tissue-specific self-antigen has so far not been identified. The disease is systemic at all stages and can affect a multitude of organ systems, including mucosae (Sjögren's syndrome), pericard, pleura, and lungs [5,6]. Pulmonary complications account for 10 to 20% of mortality in RA patients [7,8]. The pleura and the airways, as well as the interstitium and vasculature of the lung can be affected [7,8]. Pleuritis is the most common manifestation of lung disease associated with RA, but this condition often remainswww.eji-journal.eu 3224 Evelien Schurgers et al. Eur. J. Immunol. 2012. 42: 3223-3234 asymptomatic [8,9]. Rheumatoid arthritis-interstitial lung disease (RA-ILD) refers to a diverse range of pulmonary disorders that affect the interstitium of the lung. Three different interstitial pathologies can be distinguished in RA: (i) bronchiolitis, (ii) usual insterstital pneumonia (UIP), and (iii) rheumatoid nodules [6,10,11]. The pathogenesis of extra-articular complications in RA is incompletely understood and evidence for similar multiorgan involvement in C...